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Abstract
The whooping cough agent Bordetella pertussis is closely related to Bordetella bronchiseptica, which is responsible for
chronic respiratory infections in various mammals and is occasionally found in humans, and to Bordetella parapertussis, one
lineage of which causes mild whooping cough in humans and the other ovine respiratory infections. All three species
produce similar sets of virulence factors that are co-regulated by the two-component system BvgAS. We characterized the
molecular diversity of BvgAS in Bordetella by sequencing the two genes from a large number of diverse isolates. The
response regulator BvgA is virtually invariant, indicating strong functional constraints. In contrast, the multi-domain sensor
kinase BvgS has evolved into two different types. The pertussis type is found in B. pertussis and in a lineage of essentially
human-associated B. bronchiseptica, while the bronchiseptica type is associated with the majority of B. bronchiseptica and
both ovine and human B. parapertussis. BvgS is monomorphic in B. pertussis, suggesting optimal adaptation or a recent
population bottleneck. The degree of diversity of the bronchiseptica type BvgS is markedly different between domains,
indicating distinct evolutionary pressures. Thus, absolute conservation of the putative solute-binding cavities of the two
periplasmic Venus Fly Trap (VFT) domains suggests that common signals are perceived in all three species, while the
external surfaces of these domains vary more extensively. Co-evolution of the surfaces of the two VFT domains in each type
and domain swapping experiments indicate that signal transduction in the periplasmic region may be type-specific. The
two distinct evolutionary solutions for BvgS confirm that B. pertussis has emerged from a specific B. bronchiseptica lineage.
The invariant regions of BvgS point to essential parts for its molecular mechanism, while the variable regions may indicate
adaptations to different lifestyles. The repertoire of BvgS sequences will pave the way for functional analyses of this
prototypic system.
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Introduction
Bordetella pertussis, the whooping cough agent, is an extremely
contagious pathogen that infects the upper respiratory tract of
humans and causes an acute infection [1]. The expression of most
virulence factors of this Gram-negative bacterium, including
adhesins and toxins, is controlled by the BvgAS two-component
system (TCS) [2–5]. TCSs regulate major physiological responses
in bacteria [6–9]. They are composed of two proteins, a sensor
kinase that perceives (a) signal(s) and autophosphorylates a
conserved histidine residue, and a response regulator that becomes
activated upon phosphorylation by its cognate sensor kinase and
often serves as a transcriptional activator [7,10,11].
BvgS is an ‘‘unorthodox’’ sensor kinase composed of three
domains potentially involved in signal perception: two tandem
periplasmic Venus Fly Trap (VFT) domains, proteins composed of
two lobes with a solute-binding cavity between them [12] and a
cytoplasmic PAS (Per-ARNT-Sim) domain [13]. They are
followed by several domains participating to a phosphorylation
cascade: a histidine kinase (His-kinase) domain, an Asp-containing
receiver domain and a His phosphotransfer domain (Hpt) [14].
When phosphorylated, the response regulator BvgA activates the
transcription of the virulence-activated genes (vags) [15].
By controlling the intracellular concentration of phosphorylated
BvgA, this system mediates a progressive transition between three
phenotypic phases, Bvg
2 (avirulent), Bvg
i (intermediate) and Bvg
+
(virulent) [16–20]. The Bvg
+ phase occurs at 37uC and is necessary
for B. pertussis to cause respiratory infections in animal models
[16,21]. The Bvg
i phase, in which some adhesins are produced,
has been proposed to play a role in transmission and in the initial
stages of infection [22]. Under laboratory conditions, negative
signals such as nicotinate, MgSO4 or low temperature trigger
modulation to the Bvg
2 phase [23]. A set of virulence-repressed
genes (vrgs) is expressed in that phase [24].
Bordetella parapertussis and Bordetella bronchiseptica are close relatives
of B. pertussis [25–28]. Two distinct lineages of B. parapertussis cause
either a generally milder form of whooping cough in humans or
ovine respiratory infections [29–33], and B. bronchiseptica causes
chronic respiratory infections in various mammals and has also
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e6996been occasionally isolated from humans [34,35]. B. pertussis and B.
parapertussis are thought to have derived from distinct B.
bronchiseptica clones [28,33,36]. The virulence regulons of the three
species are similar. They are also controlled by BvgAS and
respond to the same negative modulators. B. bronchiseptica can
survive outside its hosts in the Bvg
2 phase, which promotes
motility and survival under nutrient-limiting conditions [37–39].
In contrast, B. pertussis and B. parapertussishu have no known
reservoir other than humans, and the function of their Bvg
2 phase
is unclear. While B. bronchiseptica is fairly responsive to negative
modulators, the sensitivity of B. pertussis to modulators appears to
vary between isolates, which might suggest that the ability to
down-modulate virulence has become dispensable for this species
[16].
Because of the diversity of hosts and the different types of
infection caused by these three Bordetella species, we investigated
here the molecular diversity and evolution of BvgAS among the
three Bordetella species. Sequencing of bvgA and bvgS from a number
of isolates revealed that BvgA is almost invariant, while BvgS
shows marked divergences between phylogenetic groups. Two
evolutionary solutions for BvgS clearly appear from the analysis.
The VFT2 domain is totally conserved within each of the two
major BvgS types, indicating its pivotal role for the function of the
protein.
Results
Genotyping of bvgA and bvgS in Bordetella
Full genomic sequences are available thus far for B. pertussis
Tohama I, the B. bronchiseptica rabbit isolate RB50, and the human
B. parapertussis isolate Bpp12822 [26]. The three genomes are
closely related, with orthologous genes displaying little diversity
between the three species. However, the bvgS genes markedly differ
between them, while in contrast the bvgA genes are highly similar,
harbouring small numbers of substitutions all of which are
synonymous. To characterize the diversity of bvgA and bvgS, these
genes were sequenced from a number of isolates selected from a
collection described earlier [28]. In that previous phylogenetic
study based on the sequences of housekeeping gene fragments, 4
major complexes of Bordetella were identified [28]. Complex I
includes B. bronchiseptica isolates mainly of animal origin and the B.
parapertussis ovine isolates (Bppov), complex II all B. pertussis isolates,
complex III all B. parapertussis human isolates (Bpphu) and complex
IV B. bronchiseptica isolates mainly of human origin. We thus
selected isolates to represent these 4 complexes and all the
sequence types identified in that study. We attempted to maximize
the diversity of hosts, geographic origins and times of isolation.
In the 82 bvgS sequences, 247 distinct single nucleotide
polymorphisms (SNPs) on a total of 3,717 bp were found (6.6%).
Among these, 147 SNPs are synonymous substitutions (3.8%) and
100 non-synonymous substitutions (2.6%). This apparent diversity
masks major differences between the Bordetella complexes (Table 1),
as well as between domains of the protein (see below). Thus, bvgS is
remarkably conserved in B. pertussis (complex II) with only two -
non silent- SNPs among all 29 isolates. This is illustrated by a very
low diversity index (0.15), which is yet lower than that calculated
from the set of housekeeping genes sequenced in [28] (0.65). In
contrast, the genetic diversity indices of both bvgS and the
housekeeping genes calculated for complex IV and for complex
I are significantly higher than those of B. pertussis (Table 1).
Although B. parapertussishu is thought to have emerged more
recently than B. pertussis [28], bvgS is more diverse in complex III
than in complex II, while the contrary is true for the housekeeping
genes (Table 1).
bvgA was found to be almost invariant, with 15 SNPs in total
(Table 1). Only three SNPs are non-synonymous, but each is
found in only one isolate. This indicates an extremely strong
pressure on bvgA in Bordetellae. Accordingly, genetic diversity in all 4
complexes is lower for bvgA than for housekeeping genes or bvgS.
Both bvgA and bvgS are strikingly conserved in B. pertussis (complex
II).
A phylogenetic tree was constructed based on the bvgS
sequences (Fig. 1). This analysis clearly distinguishes two lineages
of bvgS. The ‘‘pertussis type’’ (BvgSBp) encompasses bvgS from the 29
B. pertussis isolates as well as from the 12 B. bronchiseptica complex
IV isolates. The other type, referred to hereafter as the
‘‘bronchiseptica type’’ (BvgSBb) encompasses bvgS from all 32 isolates
that belong to the complex I of B. bronchiseptica and from the 9
isolates of B. parapertussis. Interestingly, the ovine and human B.
parapertussis isolates do not form separate clusters but are included
in the B. bronchiseptica complex I group, in contrast with previous
studies [28,40]. Similarly, the human isolates of B. bronchiseptica
complex I are found interspersed among the animal isolates and
do not form a separate group.
A comparison of the bvgS-based phylogeny with that based on
concatenated fragments from 7 different housekeeping genes
described earlier [28] showed that while the overall topology of the
two trees are similar, details differ. In addition to the absence of a
Table 1. Numerical analyses of the sequence data.
bvgA (630 bp) bvgS (3,717 bp) HKG (2,912 bp)
Complexes I II III IV Total I II III IV Total I II III IV Total
Number of isolates 38 28 6 13 85 35 29 6 12 82 35 22 6 12 75
Number of alleles 7 2 2 6 16 12 3 3 11 28 13 3 1 11 28
Total SNPs 6 1 2 6 15 68 2 20 41 247 51 2 0 20 83
Non synonymous SNPs 2 0 0 1 3 38 2 6 14 100 26 0 0 12 45
Synonymous SNPs 4 1 2 5 12 30 0 14 27 147 25 2 0 8 38
Shannon-Wiener index 1.18 0.15 0.63 1.52 2 1.72 0.29 0.86 2.37 2.42 2.34 0.65 0 2.37 2.87
The sequences of bvgA and bvgS originate from this study, while those of the 7 housekeeping gene fragments (HKG) were obtained from a previous study [28] and
concatenated for the analyses. All three sets of sequences were obtained from similar sets of isolates. The Shannon-Wiener index represents the genetic diversity.
Complex I includes B. bronchiseptica isolates mainly of animal origin and the B. parapertussis ovine isolates (Bppov), complex II all B. pertussis isolates, complex III all B.
parapertussis human isolates (Bpphu) and complex IV B. bronchiseptica isolates mainly of human origin.
doi:10.1371/journal.pone.0006996.t001
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PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e6996Figure 1. Phylogenetic tree based on the DNA sequences of bvgS. The lengths of the branches represent the phylogenetic distances. All
human B. pertussis (Bp), B. bronchiseptica (Bb) and B. parapertussis (Bpp) isolates are shown in red. The major complexes identified in an earlier study
[28] are boxed in colors, and the numbers in parentheses correspond to the sequence types defined in that study.
doi:10.1371/journal.pone.0006996.g001
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isolates in the bvgS-based tree, some of the sequence types (ST)
defined based on the housekeeping genes are split between several
different branches of the bvgS-based tree, e.g. ST6, ST16 and
ST19 (Fig. 1). These observations suggests that bvgS has evolved
somewhat differentially from the housekeeping genes in the
various branches.
Amino acid sequence analyses
To gain insight into the evolution of the functional domains of
BvgS, the predicted amino acid sequences were aligned (Fig. 2).
The two types of BvgS, BvgSBb and BvgSBp, appear distinctly from
this analysis. BvgS is identical among 27 B. pertussis isolates, while
the two strains widely used in laboratories harbour each one
substitution, E705K for Tohama I and I124T for strain 18323,
Figure 2. Schematic representation of BvgS variability at the amino acid level. The complexes I+III, II and IV are defined as in Fig. 1. The
various domains of BvgS drawn to scale are boxed in colors. The top line represents the prototype BvgS of all B. pertussis isolates but Tohama I and
18323. Each line below represents a distinct BvgS sequence, with each substitution relative to the reference sequence shown as a small vertical bar at
the corresponding position in the protein. The same substitution is systematically found at any given position. Some of the BvgS variants displayed
represent several isolates, the number of which is given in parentheses. SP represents the signal peptide, TMH the transmembrane helix, R the
receiver domain, and A, B, C and D the four linkers connecting the domains (see text).
doi:10.1371/journal.pone.0006996.g002
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BvgSBp in the three domains potentially involved in signal
perception, while the picture is slightly more blurred in the region
corresponding to the phosphotransfer domains. BvgS from B.
parapertussis resembles BvgSBb all along the sequence.
Remarkably, no more than two different residues are present at
any given sequence position of the protein in all 82 isolates
(Supporting information). Thus, in spite of the divergent evolution
of BvgS between B. bronchiseptica complex I on the one hand, and
B. pertussis and B. bronchiseptica complex IV on the other hand,
selective pressure appears to limit the possible substitutions at the
variable positions.
Our analyses revealed significant differences with respect to
domain conservation. The first periplasmic domain, VFT1 totals
the largest number of variable positions, although it is relatively
well conserved within each type. Among the 82 isolates, 37
positions are variable in VFT1 over a total of 255 residues (14.5%).
The overwhelming majority of the substitutions between the
BvgSBb and the BvgSBp VFT1 are conservative in nature. In very
rare instances, more drastic changes were observed, such as a Glu
to Lys substitution at position 83 for two B. parapertussis ovine
isolates and a Val to Glu substitution at position 206 for a single
complex I isolate (Supporting information). Unlike for B. pertussis,
some degree of variation is found within the complex IV VFT1s.
Intriguingly, 4 of the substitutions identified in complex IV are not
at the positions that differentiate BvgSBp from BvgSBb. They are
thus specific of complex IV.
One isolate, B0226, stands out from the B. bronchiseptica complex
I by a small portion of VFT1. At 7 positions between residues 133
and 166 it shares B. pertussis sequences, although it also harbours
unique substitutions in that region.
For VFT2 essentially two types of sequence have evolved. VFT2
of BvgSBp is invariant for all 41 B. pertussis and B. bronchiseptica
complex IV isolates, suggesting that this domain is under strong
stabilizing selection. VFT2 of BvgSBb also displays a very limited
degree of variation. Furthermore, only conservative substitutions
are found between the two types except for one at position 404,
where Ala in BvgSBp is replaced by Asp in BvgSBb. In total, 19
positions are different between the pertussis type and the
bronchiseptica type VFT2s over a total of 254 residues (7.5%).
There are no intermediates between the two VFT2 types. All these
observations argue that VFT2 is pivotal to the function of BvgS
and is under strong selective pressure in each lineage.
The PAS domain is well conserved among all isolates,
suggesting that it is also under stabilizing pressure. In total only
5 positions are variable, and the few substitutions found in this
domain are all conservative. Similar to VFT1 and VFT2, the PAS
domain distinguishes B. bronchiseptica complex I from B. pertussis
and B. bronchiseptica complex IV. Thus, for all three putative
perception domains, B. bronchiseptica complex IV clearly sides with
B. pertussis.
For the His-kinase domain, in contrast, B. bronchiseptica complex
IV sequences appear to be more similar to BvgSBb than to BvgSBp.
Altogether the His-kinase domain is also much more conserved
than the two VFT domains, with only 11 variable positions
harbouring essentially conservative substitutions over a total of 223
residues (4.9%). This probably points to strong functional
constraints on this domain.
The receiver domain is more diverse, with 9 variable positions
over a total of 122 residues (7.3%). Intriguingly, the receiver
domain of B. bronchiseptica complex IV is of the BvgSBp type, unlike
the His-kinase domain.
The Hpt domain is well conserved, with only 4 variable
positions for a total of 98 residues (4.1%). Intriguingly, at position
1190, the conservative Val to Ala substitution differentiates B.
pertussis from B. bronchiseptica of both complexes I and IV.
Altogether, thus, complex IV appears to be intermediate between
the BvgSBb and the BvgSBp types for the His-kinase and Hpt
domains, in contrast with the VFT1, VFT2, PAS and receiver
domains. This suggests that the distinct domains have evolved at
different rates.
Distinct functional constraints appear to operate also on the
various linkers that join the domains. The transmembrane helix is
invariant, except for a unique conservative Gly to Ala change.
Similarly, the linkers A and B between the membrane and the PAS
domain and between the PAS and His-kinase domains respectively
are invariant, indicating that they are under strong selective
pressure (Fig. 2). One striking exception to this rule is that a Glu
residue is replaced by a Lys residue in Tohama I at position 705
(see below). In marked contrast with the strict conservation of
linkers A and B, the linker C between the His-kinase and receiver
domains seems to accumulate a disproportionate number of
mutations, with 20% positions that are variable. Linker D between
the receiver and Hpt domains harbours 2 variable positions over
36 residues.
Mapping of the substitutions
In order to map the positions of the substitutions, structural
models were constructed for several domains of BvgS based on
available X-ray structures of homologous proteins, since the crystal
structure of BvgS is not available. VFT1 and VFT2 were modelled
on the glutamine-binding protein, a bacterial periplasmic binding
protein of an ABC transporter. The overwhelming majority of the
substitutions between the two broad phylogenetic groups map to
the external surfaces of both VFT1 and VFT2, leaving the
potential solute-binding cavities conserved (Fig. 3). In addition, a
few substitutions appear to be in the hydrophobic core of VFTs,
but they are highly conservative and thus unlikely to affect the
structure or stability of the proteins. Thus, the tertiary structures of
the two VFT domains and their potential ligand-binding pockets
are likely to be totally conserved, while the external surfaces of the
proteins are quite different between the two BvgS types. The more
drastic substitution between BvgSBp (Asp404) and BvgSBb (Ala404)i s
located in an external loop in the second lobe of VFT2. Unlike
non-synonymous substitutions, synonymous substitutions are
found both in the ligand binding cavities and on the surfaces of
the VFTs, indicating differential selective pressure between cavities
and surfaces.
A model of the His-kinase domain of BvgS was also constructed.
The ATP-binding pocket appeared to be conserved among all
isolates, as expected for the activity of the protein (not shown). A
drastic substitution located in the linker B that precedes the His-
kinase domain distinguishes B. pertussis Tohama I from all other B.
pertussis, B. bronchiseptica and B. parapertussis isolates. Tohama I
harbours a Lys at position 705 instead of a Glu in the 81 others.
This linker is predicted to form an a helix immediately preceding
the dimerisation helix of the His-kinase domain. Conceivably, this
substitution might affect the conformation of this region most
likely crucial for signal transduction (see below).
The structure of an Hpt domain in complex with its cognate
phosphorylation substrate has been reported [41,42], showing the
interface between the two proteins. The BvgS Hpt domain has two
interaction partners, the receiver domain and BvgA. The surfaces
of Hpt predicted to form interfaces with its partners appear to be
conserved as well (not shown). Similarly, neither of the three
frequent substitutions between the receiver domains of the two
BvgS types map to the predicted interface with Hpt (not shown).
Molecular Evolution of BvgAS
PLoS ONE | www.plosone.org 5 September 2009 | Volume 4 | Issue 9 | e6996Figure 3. Structural models of VFT1 and VFT2. The models of VFT1 (A) and VFT2 (B) are based on the structure of the glutamine binding
protein in an unliganded, open conformation (PDB 1GGG). The elements of secondary structure are shown in ribbon representation in lime green,
and the surfaces of the proteins are shown in semi-transparency. The cavity of each of the two domains corresponds to the groove between the two
lobes. The positions of the substitutions that distinguish the BvgSBp and BvgSBb types are depicted as red balls. Only the main chain atoms are shown.
The rare substitutions have not been represented.
doi:10.1371/journal.pone.0006996.g003
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one isolate, namely Glu to Gly, Asp to Gly and Val to Glu at
positions 64, 137 and 197, respectively. Sequence alignments of
response regulators homologous to BvgA as well as the X-ray
structure of one such protein indicate that these three substitutions
are at non-conserved positions in the superfamily (not shown). The
rarity and the positions of non-synonymous replacements in BvgA
strongly indicate that the protein is under stringent selection.
Functional implications of sequence variations
Thus the vast majority of the predicted amino acid differences
between pertussis type and bronchiseptica type BvgS are located in the
periplasmic domains, essentially at the surface of the two VFT
domains that appear to have co-evolved within each lineage. This
suggests that the two domains operate together through inter-
domain interactions, most likely for proper signal transduction. To
test this hypothesis, we determined whether the sequence
variations identified between the VFT1 and VFT2 of the two
types of BvgS affect its activity or its level of sensitivity to the
known negative virulence modulators. BvgS harbouring the
BvgSBp periplasmic domain of our laboratory strain B. pertussis
BPSM, a Tohama I derivative, was substituted with BvgS
harbouring the BvgSBb periplasmic domain from B. bronchiseptica
RB50, a typical complex I isolate (Fig. 4A). We also performed
single domain exchanges. The activities of chimeric BvgS proteins
and their responses to modulation were determined using the
reporter gene lacZ placed under the control of the Bvg-regulated
promoter of the pertussis toxin operon.
The replacement of both VFT1 and VFT2 of the BPSM BvgS
by those of RB50 (BPBb1+2) did not affect the level of BvgS activity
in the absence of modulation, but it made the recombinant
bacteria much more sensitive to nicotinic acid than their parent
(Fig. 4B,C). Thus, the BvgSBb and BvgSBp periplasmic domains of
BvgS influence the response to this negative modulator.
Similarly, the replacement of the BPSM VFT2 by that of RB50
(BPBb2), yielding a VFT1Bp-VFT2Bb chimera strongly enhanced
the sensitivity of BvgS to both nicotinic acid and MgSO4
(Fig. 4B,C). In contrast, introduction of the RB50 VFT1 into
the BPSM BvgS (BPBb1) did not modify the response of the
recombinant bacteria to either modulator (not shown). Thus,
VFT2 is essential in determining sensitivity to modulation.
Because of its drastic character in an otherwise totally invariant
linker segment, the substitution identified in the Tohama I BvgS
was also investigated. Tohama I has been described as relatively
insensitive to modulation compared with other B. pertussis isolates
[16], and thus we tested whether Lys705 is the cause for this lack of
sensitivity (Fig. 5A). Glu at position 705 in the BPSM BvgS made
the recombinant strain more responsive to nicotinate than its
parent, with 4 mM nicotinic acid causing the complete loss of
BvgS activity (Fig. 5B). The BPE705 substitution also enhanced the
responsiveness to MgSO4 (Fig. 5C). Thus, the presence of a Lys at
position 705 is responsible for the lack of sensitivity to modulation
of Tohama I. This substitution is quite rare in Bordetella, suggesting
that the mutation acquired in Tohama I is not particularly
advantageous. The other unique substitution identified in
Bp18323, I124T, was also introduced into BPSM (BPT124). The
level of ß-gal activity and the responsiveness to modulators of
BPT124 was identical to that of BPSM, indicating that this is likely
a neutral substitution (not shown).
Since both VFT2 and the linker preceding the HK domain
determine the sensitivity to modulators, we tested whether their
effects are cumulative. Therefore, a new chimeric strain,
BPBb2+E705 was constructed that harbours both the VFT2Bb
domain and Glu at position 705 (Fig. 5A). BPBb2+E705 was
hypersensitive to modulators, with as low as 0.25 mM nicotinic
acid (Fig. 5B) or 5 mM MgSO4 (Fig. 5C) being sufficient for
complete modulation.
Hypermodulator B. pertussis in an animal model of
infection
No such hypersensitive variant has been characterized in
natural isolates so far [16]. Thus, it was interesting to determine
Figure 4. ß-galactosidase activities of the recombinant
BPSM(ptx::lacZ) strains harbouring BvgS variants. (A) Schematic
representation of the chimeric BvgS, with the white boxes representing
BvgSBp domains and the shaded boxes BvgSBb domains. BPWT
corresponds to BPSM carrying the reporter gene. HK represents the
His-kinase domain. (B) and (C) The ß-gal activities were measured as a
function of increasing concentrations of nicotinate or MgSO4. The
measurements were performed in triplicate using different clones for
each recombinant strain. The level of ß-gal activity in non-modulated
medium was taken as 100%.
doi:10.1371/journal.pone.0006996.g004
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the respiratory tract in an animal model of infection. BPSM or
BPBb2+E705 were instilled intranasally to two groups of mice, and
the numbers of bacteria recovered from the lungs were counted
after various periods of time. No significant difference was
observed between the two strains (not shown). To determine
whether BPBb2+E705 might be disadvantaged in a mixed infection,
mice were also inoculated intranasally with equal numbers of the
two bacterial strains together. The two strains colonized the lungs
of mice in the same manner (Fig. 6). Thus, in this model of
experimental infection, B. pertussis hypersensitive to modulation
does not appear to be defective for colonization.
Discussion
In this work, we investigated the molecular evolution of the
BvgAS two-component system, which is central to the regulation
of Bordetella virulence. BvgA is remarkably conserved. In contrast,
the sequences of BvgS differ markedly between species, and in
particular can be separated into two lineages of Bordetella.
Interestingly, one of the two lineages includes all B. pertussis
isolates and a subset of B. bronchiseptica isolates previously identified
as forming a distinct B. bronchiseptica complex (called complex IV),
mainly isolated from humans [28]. Our results confirm the
hypothesis that complex IV strains are an evolutionary interme-
diate between animal and human adapted Bordetellae from which B.
pertussis evolved [28]. The degree of divergence of BvgS varies
significantly between lineages, as shown by the genetic diversity
indices. In B. pertussis, BvgS displays an extremely low level of
diversity, indicating that it has reached equilibrium in this highly
successful human colonizer or has undergone a recent selective
sweep. With a broad range of hosts, complex IV may be using a
different evolutionary strategy, and its BvgS may still be in a
process of diversification.
Our analyses do not provide evidence of an absolute correlation
between the type of bvgS allele found in a given Bordetella lineage
and the hosts of its members. Thus, two bona fide human
pathogens, B. pertussis and B. parapertussishu, harbour BvgS of the
BvgSBp type and of the BvgSBb type, respectively, although the
latter type otherwise corresponds to B. bronchiseptica complex I,
with isolates of essentially animal origin. Similarly, the ovine and
human isolates of B. parapertussis have the same BvgS type although
they infect distinct hosts. It is interesting that BvgS is monomor-
phic in B. pertussis but not in B. parapertussishu, as B. pertussis is
assumed to be older [28]. This may reflect that B. parapertussishu is
not yet optimally adapted to its host, unlike B. pertussis [33].
Remarkably, the various domains of BvgS display widely
different degrees of diversity, which shows that they are under
different functional constraints, and/or parts of the protein are
subject to diversifying selection in some lineages. The periplasmic
domains of BvgS appear to have evolved most extensively.
However, their evolution has been restricted to external surfaces,
strongly arguing that the binding paradigm for Venus Fly Trap
Figure 5. ß-galactosidase activities of the recombinant
BPSM(ptx::lacZ) strains harbouring BvgS variants. (A) Schematic
representation of the chimeric BvgS. The BvgS domains are represented
as in Fig. 4. The star indicates that the Lys705 residue found in Tohama I
was replaced by Glu as in all other isolates. (B) and (C) The ß-gal
activities were measured as a function of increasing concentrations of
nicotinate or MgSO4. The measurements were performed as in Fig. 4.
doi:10.1371/journal.pone.0006996.g005
Figure 6. Colonization of mice lungs by two strains in a mixed
infection. Balb/c mice were infected intranasally by 1.6610
5 CFU of
each BPSMGWT and BPBb2+E705. At the indicated time points, mice were
killed, and the viable bacteria present in the lungs were counted. 5 mice
were analyzed per time point. The two bacterial strains were
distinguished by an antibiotic marker. Medians for each group are
shown.
doi:10.1371/journal.pone.0006996.g006
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cavities argues that they bind specific ligands. The prevalent model
proposes that BvgS is in a permanently activated state in the
absence of ligand, unlike classical sensors of TCS. If this is correct,
then the conservation of the cavities is important essentially for the
perception of negative signals. However, we have obtained
preliminary data that specific substitutions in the VFTs cavities
markedly decrease the activity of BvgS (our unpublished data).
This supports the idea that the cavities of the VFT domains also
perceive positive signals, at odds with the generally accepted
model.
The external surfaces of the VFT domains have evolved
considerably, arguing that they undergo a lesser selective pressure
or are even diversifying. However, because there are no
intermediate types between the BvgSBb and BvgSBp types, the
evolutionary pressure must have selected for functional combina-
tions of the two VFT surfaces. In other words, the surfaces may
have co-evolved in each of the two major lineages because
interactions between the two domains must be fine-tuned for
optimal function. The combination of VFT1Bp and VFT2Bb in
particular appears to significantly increase the sensitivity of BvgS
to modulators. We thus propose that the sensitivity to modulators
depend on the efficiency of signal transduction between the two
VFT domains and between VFT2 and the cytoplasmic portion
through the membrane segment. The membrane-proximal
position of VFT2 most likely makes it especially important in this
respect. Similarly, the two types of BvgS harbour distinct sets of
cytoplasmic domains, although the situation is more blurred in the
case of complex IV. This suggests that there may be small
functional differences in the phosphorylation cascade between the
two types.
The region of the protein with the lowest degree of diversity
encompasses the transmembrane segment, the following cytoplas-
mic linker and the PAS and His-kinase domains, emphasizing the
functional constraints on that region. The transmembrane
segment must transmit signals perceived by the periplasmic
domain to the cytoplasmic domain in a purely mechanical
manner, such as a rotational or a piston-like motion. This signal
must then be conveyed mechanically by the linker to the PAS
domain, and then from the PAS domain to the His-kinase domain.
PAS is thus central to transduction between periplasmic and His-
kinase domains. In agreement with this model, several mutations
that make BvgS insensitive to negative modulating signals map to
the linker and PAS domains [43,44]. Following phosphorylation of
the His-kinase, signal transmission to BvgA is enzymatic, and thus
functional constraints are exerted on the interfaces between
domains, for interactions in trans and/or in cis, rather than on
linkers [45]. In agreement with this idea, the linkers between the
domains involved in the phosphorylation cascade have diverged
more rapidly, most likely because they do not undergo strong
selective pressures.
Only 3 rare substitutions were identified in BvgA. BvgA forms
many interactions that are all important for its function. It forms
homodimers, interacts with the Hpt domain for phosphotranfer
and with its target DNA sequences and the RNA polymerase. This
most likely explains why BvgA undergoes such a strong stabilizing
pressure in pathogenic Bordetellae.
The importance of responsiveness to modulating agents for the
function of BvgS in vivo, and the relevance of nicotinate and
MgSO4 are unclear. The Bvg
2 phase is most likely more
important for B. bronchiseptica to survive outside the host and cause
chronic infections [46,47] than it is for the lifestyle of B. pertussis.
Nevertheless, the fact that both types of BvgS have retained similar
sensitivities to negative modulators argues that this phenotype is
nevertheless relevant for both species. Thus, no natural B. pertussis
isolates appear to be ‘‘locked’’ in the Bvg
+ phase, even though such
strains can arise by simple point mutations in the laboratory
[43,44,48]. Therefore, the ability to down-modulate virulence
factor expression must confer some advantage upon the
bacterium, which is supported by the fact that Tohama I, with
its low sensitivity to modulators, is the exception among B. pertussis.
Conversely, we wondered whether B. pertussis with a BvgS variant
hypersensitive to modulation would be impaired for colonisation.
Surprisingly, this strain appeared to be functional in the mouse
model of infection. The observation that no naturally occurring
Bordetella isolate has been described to harbour such a hyper-
responsive BvgS nevertheless suggests that this phenotype might be
detrimental. The animal model used in this study does not
reproduce all the features of a human infection, and in particular




All animal experiments were performed at the animal facility of
the Institut Pasteur de Lille (number A59-35-064, Lille, France)
according to the rules of the European Community Council
guidelines (86/609/EEC) for laboratory animal experimentation.
The animal protocol was approved by the local institutional review
board (Comite ´d ’ Ethique en Expe ´rimentation Animale Nord-Pas-
De-Calais, CEEA 03/2009).
Sequencing of the circulating infectious Bordetella
isolates
The B. pertussis, B. bronchiseptica and B. parapertussis isolates were
selected from the collection described in [28]. bvgS was sequenced
for 28 isolates of B. pertussis, 8o fB. parapertussis (5 Bpphu and 3
Bppov), 31 of B. bronchiseptica from complex I and 12 of B.
bronchiseptica from complex IV [28] (Table S2). bvgA was sequenced
from 27 isolates of B. pertussis,8B. parapertussis isolates (5 Bpphu and
3 Bppov), 34 B. bronchiseptica isolates from complex I and 13 from
complex IV (Table S3). The strains were cultivated on BG blood
agar medium during 16 hours for B. bronchiseptica and 48 hours for
B. pertussis and B. parapertussis. Chromosomal DNA was extracted
using the Illustra
TM bacterial genomic Prep Mini Spin Kit (GE
Healthcare) according to the manufacturer’s instructions. For
PCR amplification, several partially overlapping PCRs were
performed by using several pairs of primers, bvgA9-Up and
bvgA9-Lo, VFT19-Up and VFT19-Lo, VFT29-Up and VFT29-Lo,
PAS/HisKin-Up and PAS/HisKin-Lo, R-Up and R-Lo and Hpt-
Up and Hpt-Lo (Table S1). The following conditions for the mixes
were used: HotStar Taq DNA polymerase in the presence of Q
buffer and MgCl2 (Qiagen), 30 cycles of 1 min at 95uC, 1 min at
57uC and 1 min at 72uC. The PCR products were purified by
using the PCR Purification Kit or the Gel Extraction Kit (Qiagen),
depending on the degree of purity of the amplicons. The DNA
fragments were sequenced by Genoscreen using an ABI 377
sequencer (Lille, France). The sequences were reassembled and
compared by using the DNAstar software. A number of targets
were amplified and sequenced twice to determine the level of error
introduced by the PCR and sequencing steps. In particular, all
fragments with a unique sequence type were checked in this
manner. No discrepancy was obtained in any case.
Sequence data analysis
The genetic diversity for each complex was calculated using the
Shannon-Wiener index of diversity using the following formula in
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Single nucleotide polymorphisms (SNP) and their synonymous
or non-synonymous characteristics were evaluated by using the
DnaSP software. Neighbour-joining trees were constructed by
using the www.phylogeny.fr software.
Models of the BvgS domains
The PDB codes of the X-ray structures used to build models for
the various domains of BvgS are 1GGG (VFTs), 2C2A (His-
kinase), 2AYX (receiver domain) and 2AOB (Hpt domain), and
3C3W for BvgA. The Modeller software was used on the following
portions of BvgS: residues 33–287 for VFT1, 288–541 for VFT2,
726–946 for the His-kinase domain, 974–1095 for the receiver
domain and 1133–1228 for the Hpt domain.
Construction of chimeric B. pertussis strains
B. pertussis BPSM is a Tohama I-derivative that is resistant to
streptomycin [49]. The bvgAS deletion strain BPSMDbvgAS was
constructed as follows. The 59 and 39 extremities of the bvgAS locus
were amplified by PCR using the BPSM chromosome as template
and the oligonucleotides bvgA-Up and bvgA0-Lo, and bvgS-Up
and bvgS-Lo as primers, respectively (Table S1). The amplicons
were inserted directly into pCRHII-TOPO (Invitrogen) and
sequenced. They were then successively introduced as EcoRI-KpnI
and XbaI-HindIII fragments into pUC19, yielding pUC19DbvgAS.
The resulting 1.0 kb EcoRI-HindIII fragment was introduced into
the EcoRI-HindIII sites of pSORTP1, a mobilizable plasmid used
for conjugation [50]. Conjugation was performed on BG-blood
agar plates containing 10 mg/ml MgCl2 for 6–7 hours, and co-
integrates were selected on BG-blood agar plates containing
10 mg/ml gentamycin and 30 mg/ml nalidixic acid to prevent
growth of the E. coli donor. Allelic exchange was selected by two
successive steps as described [50]. After 4 to 5 days growth on
selective media, isolated non-haemolytic streptomycin-resistant
colonies, characteristic of the Bvg
2 phase were analysed by PCR
to confirm the deletion.
Recombinant BPSM strains containing chimeric bvgS genes
were constructed as follows. Successive portions of the bvgAS locus
of BPSM were amplified by PCR in order to introduce restriction
sites using silent mutations at specific sites corresponding to
junctions between structural domains. The sequences of the
oligonucleotides used as primers are given in Table S1. In
addition, an EcoRI restriction site naturally occurring in the region
of the gene coding for the PAS/His-kinase portion of bvgS was
removed by overlapping PCR using the pairs of primers DEcoRI-
Up and PAS/HisKin-Lo, and DEcoRI-Lo and PAS/HisKin-Up.
The various amplicons were sequenced and introduced succes-
sively into pUC19. The resulting ‘‘mosaic’’ bvgAS locus includes
the 59 and 39 extremities of the operon remaining in BPSMDbvgAS
and necessary for allelic replacement in that strain. The mosaic
bvgAS locus allowed us to replace selectively the genetic cassettes
encoding each of the two VFT-like domains and the PAS/His-
kinase domains of the BPSM bvgS by the corresponding cassettes of
B. pertussis 18323 (to introduce Glu705) or B. bronchiseptica RB50.
This procedure generated a number of bvgS variants that were
each excised from pUC19 by restriction with EcoRI and HindIII
and introduced into the EcoRI and HindIII sites of pSORTP1.
Each bvgS variant was then introduced into BPSMDbvgAS by allelic
exchange, using conjugation as described above. Our criterion for
the selection of recombinant clones was the restoration of
hemolysis, which can be easily detected on BG-blood agar.
Construction of ptx-lacZ transcriptional fusions and
measurement of ß-galactosidase activity
A recombinant pFUS plasmid, harbouring lacZ in transcrip-
tional fusion with the sequence of the first gene of the pertussis
toxin operon [51], was introduced into the different strains by
conjugation, and the integrants were selected on BG blood agar
containing 100 mg/ml streptomycin and 10 mg/ml gentamycin.
The recombinant strains were grown in modified Stainer-Scholte
medium (SS) [52] containing the relevant antibiotics. After
overnight growth at 37uC under rotating agitation, the bacterial
suspension was used to initiate cultures in 10 ml of SS medium
containing increasing concentrations of nicotinate or MgSO4. The
inoculation volume was adapted to compensate for slower growth
in the presence of high concentrations of nicotinate. The bacteria
were grown until the cultures reached an OD600 of 1.5. They were
harvested by centrifugation and broken by using a Hybaid
Ribolyser apparatus (35 s at speed 6 in tubes containing 0.1 mm
silica spheres as the lysing matrix). ß-galactosidase activities were
measured as described [51]. The experiments were performed in
triplicate.
Murine respiratory tract infections
Experimental infections were performed at biosafety level 2
facilities with 8 week-old female BALB/c mice purchased from
Charles River Laboratories.
Two groups of mice slightly sedated by intraperitoneal
pentobarbital injection were inoculated with 1.6610
6 bacteria
from BPSM and BPBb2+E705 suspensions, by depositing 20 ml
droplets into the nostrils. Groups of four animals per strain were
sacrificed at days 0, 7, 14, 21 and 28 post-inoculation, and lungs
were removed. Lung colonization was quantified by homogenizing
the entire lungs in 2 to 5 ml phosphate-buffered saline (PBS),
plating 100 ml aliquots of serial dilutions of the lung suspensions
onto BG blood agar with 100 mg/ml of streptomycin, and
counting the colonies after 4 days of incubation at 37uC.
Mixed infection essays were performed with BPSM carrying a
gentamycin resistance marker at the 39 end of the bctCBA operon
[53] to distinguish between this strain (called hereafter
BPSMGWT) and BPBb2+E705. In this case, the inoculum consisted
of 1.6610
5 CFU of each bacterial strain suspended in a final
volume of 20 ml. Five animals per time point were sacrificed at
days 0, 3, 7, 14, 21 and 28 post-inoculation and lung colonization
was quantified as described above. Serial dilutions of each
suspension were plated onto BG blood agar with 100 mg/ml of
streptomycin or with 10 mg/ml of gentamycin. Colonies grown on
gentamycin (corresponding to BPSMGWT) were subtracted from
the number of colonies present on the streptomycin-containing
medium (corresponding to both BPSMGWT and BPBb2+E705)t o
determine the number of BPBb2+E705 bacteria present in the mice
lungs.
Supporting Information
Table S1 Oligonucleotides used in this study
Found at: doi:10.1371/journal.pone.0006996.s001 (0.07 MB
PDF)
Table S2 bvgS sequences
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RTF)
Table S3 bvgA sequences
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